Core Viewpoint - Corcept Therapeutics is under investigation for potential securities law violations following a disappointing response from the FDA regarding its drug application for relacorilant, leading to a significant drop in its stock price [1][2][3]. Investigation Details - On December 31, 2025, Corcept announced that the FDA issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for relacorilant, which is intended for treating hypertension secondary to hypercortisolism. The company expressed surprise and disappointment at this outcome [2]. - Following the announcement, Corcept's stock price fell by $35.40, closing at $34.80 per share on the same day [2]. - On January 30, 2026, it was reported that Corcept's shares fell an additional 16% after a corrected CRL indicated that the FDA had previously warned the company against submitting its drug application [3]. Company Background - Corcept Therapeutics is based in Redwood City, California, and focuses on developing treatments for patients with severe metabolic and psychiatric disorders [1]. - Berman Tabacco, the law firm investigating Corcept, has a history of prosecuting securities cases on behalf of investors and has been recognized for its work in this field [4].

Core Viewpoint - OneStream is under scrutiny following a downgrade by Exane BNP Paribas and an investigation into a take-private transaction that may affect shareholder interests [1][2] Group 1: Rating Change - Exane BNP Paribas downgraded OneStream from "Outperform" to "Neutral" on January 15, 2026 [1] - This downgrade coincides with significant events surrounding a take-private transaction [1] Group 2: Take-Private Transaction - OneStream is set to be acquired by Hg Capital for approximately $6.4 billion in cash, with shareholders receiving $24 per share [2] - The acquisition involves minority investors General Atlantic and Tidemark, while KKR plans to liquidate its stake [2] - An investigation by Berman Tabacco is focused on the fairness of the transaction and potential insider benefits [2] Group 3: Stock Performance - OneStream's stock is currently trading at $23.64, with a daily fluctuation between $23.62 and $23.69 [3] - Over the past year, the stock reached a high of $30.93 and a low of $16.51 [3] - The company's market capitalization is approximately $6.23 billion, with a trading volume of 2,511,452 shares [3]

Core Viewpoint - Berman Tabacco is investigating potential stockholder claims regarding OneStream's take-private transaction by Hg Capital, General Atlantic, and Tidemark, focusing on the fairness of the deal for shareholders [1][2]. Group 1: Transaction Details - On January 6, 2026, OneStream announced a take-private transaction to be acquired by Hg for approximately $6.4 billion in cash, with shareholders receiving $24.00 per share [2]. - Hg is collaborating with minority investors General Atlantic and Tidemark, while majority stockholder Kohlberg Kravis Roberts & Co. LP (KKR) will liquidate its stake in OneStream [2]. Group 2: Investigation Focus - Berman Tabacco is examining whether certain insiders at OneStream may benefit disproportionately compared to average shareholders through this transaction [2]. - The investigation will also assess if the board of directors or officers breached their fiduciary duties in pursuing this transaction [3].

Core Viewpoint - Berman Tabacco is investigating potential stockholder claims against SelectQuote, Inc. regarding allegations of illegal payments received from health insurance providers [1][2]. Investigation Details - Allegations against SelectQuote were unsealed in May 2025, involving claims that the company received illegal payments totaling over 80 million dollars from Humana and Aetna between 2016 and 2021 [2]. - The complaint suggests that SelectQuote was incentivized to direct customers towards Medicare offerings from these insurance carriers [2]. - It is alleged that senior officers of SelectQuote were personally involved in this scheme, leading to a significant decline of approximately 20% in SelectQuote's shares following the Department of Justice's complaint [2]. Board and Fiduciary Duties - Berman Tabacco is examining whether SelectQuote's board of directors played a role in the alleged scheme and if there were breaches of fiduciary duties by its officers and/or directors [3].

Core Viewpoint - Berman Tabacco is investigating potential stockholder claims against Humana, Inc. regarding allegations of illegal kickbacks paid to insurance brokers [1][2] Group 1: Allegations and Investigation - Allegations against Humana involve the payment of illegal kickbacks totaling possibly up to $250 million to insurance brokers, including Select Quote, to direct customers towards Humana's Medicare offerings [2] - The investigation was prompted by a whistleblower and has been supported by the U.S. Attorney's Office for the District of Massachusetts [2] - The complaint suggests that senior officers of Humana were personally involved in the alleged scheme [2] Group 2: Impact on Stock Performance - Following the filing of the complaint, shares of Humana experienced a decline of approximately 3% [2] Group 3: Board and Fiduciary Duties - Berman Tabacco is examining whether Humana's board of directors had a role in the alleged kickback scheme and if there were breaches of fiduciary duties by its officers and/or directors [3]

Core Viewpoint - Berman Tabacco is investigating potential stockholder claims against Live Nation Entertainment, Inc. for allegedly deceiving consumers and violating federal law [1] Investigation Details - The Federal Trade Commission (FTC) and seven states filed a civil complaint against Live Nation and Ticketmaster, alleging systematic violations of federal law that generated hundreds of millions in revenue through deceptive practices [2] - The complaint highlights a specific incident where a broker used multiple accounts to purchase 9,000 tickets for a Beyonce concert, reselling 2,500 tickets at inflated prices, resulting in additional fees for Live Nation and Ticketmaster [2] Management Involvement - Allegations suggest that senior officers of Live Nation and Ticketmaster were complicit in the deception, instructing management to ignore ticket brokers bypassing enforcement measures [3] - Following the FTC's complaint, Live Nation's shares experienced a decline of approximately 3% [3] Board Investigation - Berman Tabacco is examining whether the board of directors of Live Nation played a role in the alleged scheme and if there were breaches of fiduciary duties by its officers and/or directors [4]

Core Points - Berman Tabacco is investigating potential stockholder claims against SelectQuote, Inc. regarding allegations of illegal payments from health insurance providers [1] - Allegations suggest that SelectQuote received illegal payments exceeding 80 million dollars from Humana and Aetna between 2016 and 2021 to direct customers towards their Medicare offerings [2] - The investigation will examine the involvement of SelectQuote's board of directors and whether there were breaches of fiduciary duties by its officers and/or directors [3] Investigation Details - The allegations were unsealed in May 2025 after the U.S. Attorney's Office for the District of Massachusetts intervened, joining claims initially raised by a whistleblower [2] - Following the filing of the Department of Justice's complaint, SelectQuote's shares declined approximately 20% [2]

Core Viewpoint - Berman Tabacco is investigating the proposal by controlling stockholders of Grindr Inc. to take the company private by cashing out public stockholders at $18.00 per share [1][2][3] Investigation Details - On October 14, 2025, Grindr received a letter from controlling stockholders George Raymond Zage, III and James Fu Bin Lu expressing interest in a going-private transaction [2] - On October 24, 2025, Zage and Lu made an offer to purchase all Grindr shares from minority stockholders for $18.00 per share [2] - Concerns have been raised regarding the independence of the special committee appointed by Grindr to review the transaction, especially since it previously authorized stock buybacks that increased Zage's ownership past 50% [2] - There is no indication that the transaction will require the affirmative vote of a majority of minority stockholders [2] Legal Investigation - Berman Tabacco is examining whether Grindr's controlling stockholders and board of directors have breached their fiduciary duties to stockholders in relation to the proposed transaction [3]

BOSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that a securities class action alleging violations of the Securities Exchange Act of 1934 has been filed against Compass Diversified Holdings ("Compass" or the "Company") (NYSE: CODI), and others, on behalf of persons or entities who purchased or otherwise acquired publicly traded Compass securities between May 1, 2024, and May 7, 2025, inclusive (the "Class Period"). The case is styled, Matthews v. Compass Group Diversified Holdings, LLC, et ...

BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI). About the Investigation On May 7, 2025, after the markets closed, Compass filed a Form 8-K which stated that the Audit Committee of Board of Directors “commenced an internal investigation into the financing, accounting, and inventory practices of Lugano Holding, Inc. (‘Lugano’), a subsidiary and operating se ...